TY - JOUR
T1 - Microglandular Adenosis
T2 - A Possible Non-Obligate Precursor to Breast Carcinoma With Potential to Either Luminal-Type or Basal-Type Differentiation
AU - Damron, Alexander T.
AU - Korhonen, Katrina
AU - Zuckerman, Samantha
AU - Tchou, Julia
AU - Dumoff, Kimberly L.
AU - Bleiweiss, Ira J.
AU - Nayak, Anupma
N1 - Publisher Copyright:
© The Author(s) 2019.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Microglandular adenosis (MGA) of the breast is exceedingly rare, with only a few case reports and series published to date. Previous studies have elegantly demonstrated the progression of benign MGA to atypical MGA to MGA-in situ carcinoma to invasive carcinoma and therefore suggest MGA as a possible non-obligate precursor lesion to a subset of breast carcinomas. Immunohistochemically, MGA is negative for estrogen receptor (ER), progesterone receptor (PR), and HER2-neu oncoprotein expression, and carcinomas arising in the setting of MGA are often reported to be triple negative. In this article, we present a unique case of an ER+/PR+/HER2− invasive carcinoma associated with MGA and atypical MGA. Our case highlights the diagnostic pitfall of MGA and suggests that MGA is a heterogeneous group of lesions with potential for either luminal-type or basal-type differentiation during progression to breast carcinoma.
AB - Microglandular adenosis (MGA) of the breast is exceedingly rare, with only a few case reports and series published to date. Previous studies have elegantly demonstrated the progression of benign MGA to atypical MGA to MGA-in situ carcinoma to invasive carcinoma and therefore suggest MGA as a possible non-obligate precursor lesion to a subset of breast carcinomas. Immunohistochemically, MGA is negative for estrogen receptor (ER), progesterone receptor (PR), and HER2-neu oncoprotein expression, and carcinomas arising in the setting of MGA are often reported to be triple negative. In this article, we present a unique case of an ER+/PR+/HER2− invasive carcinoma associated with MGA and atypical MGA. Our case highlights the diagnostic pitfall of MGA and suggests that MGA is a heterogeneous group of lesions with potential for either luminal-type or basal-type differentiation during progression to breast carcinoma.
KW - MGA
KW - MGA carcinoma
KW - MGA in situ
KW - atypical microglandular adenosis
KW - microglandular adenosis
KW - microglandular adenosis biomarkers
KW - microglandular adenosis estrogen receptor
KW - microglandular adenosis immunohistochemistry
KW - microglandular adenosis precursor
UR - http://www.scopus.com/inward/record.url?scp=85065407648&partnerID=8YFLogxK
U2 - 10.1177/1066896919845493
DO - 10.1177/1066896919845493
M3 - Article
C2 - 31046496
AN - SCOPUS:85065407648
SN - 1066-8969
VL - 27
SP - 781
EP - 787
JO - International Journal of Surgical Pathology
JF - International Journal of Surgical Pathology
IS - 7
ER -